{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:58:28Z","timestamp":1791421108835,"version":"4.3.3"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2015R1A2A1A13027811"],"award-info":[{"award-number":["2015R1A2A1A13027811"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2013M3A9D3045879"],"award-info":[{"award-number":["2013M3A9D3045879"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jconrel.2015.10.015","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T12:42:17Z","timestamp":1445776937000},"page":"766-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"PB","title":["Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model"],"prefix":"10.1016","volume":"220","author":[{"given":"Youjin","family":"Na","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joung-Woo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayananda","family":"Kasala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinWoo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eonju","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Jung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae-Ok","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2015.10.015_bb0005","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1053\/j.gastro.2013.01.068","article-title":"The epidemiology of pancreatitis and pancreatic cancer","volume":"144","author":"Yadav","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-62703-287-2_9","article-title":"Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine","volume":"980","author":"Laheru","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0020","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/sonc.2002.37381","article-title":"Future directions in the treatment of pancreatic cancer","volume":"29","author":"Haller","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0889-8588(01)00009-0","article-title":"Management of locally advanced adenocarcinoma of the pancreas","volume":"16","author":"Ryan","year":"2002","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0889-8588(01)00002-8","article-title":"Immunotherapy for pancreatic cancer: current concepts","volume":"16","author":"Kaufman","year":"2002","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0040","series-title":"Pancreatic Cancer and Tumor Microenvironment (Trivandrum (India))","article-title":"Pancreatic stellate cells and fibrosis","author":"Phillips","year":"2012"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0045","doi-asserted-by":"crossref","first-page":"11745","DOI":"10.1158\/0008-5472.CAN-06-2322","article-title":"Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH(2)-terminal kinase 1 and up-regulating N-cadherin expression","volume":"66","author":"Shintani","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0050","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1053\/j.gastro.2007.01.031","article-title":"Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity","volume":"132","author":"Erkan","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.mt.6300321","article-title":"Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide","volume":"16","author":"Kreppel","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/gt.2009.142","article-title":"Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy","volume":"17","author":"Choi","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0065","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.biomaterials.2010.10.031","article-title":"Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0070","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1189\/jlb.69.4.622","article-title":"Adenoviral gene delivery can inactivate Kupffer cells: role of oxidants in NF-\u03baB activation and cytokine production","volume":"69","author":"Wheeler","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0075","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/mt.2013.100","article-title":"FX and host defense evasion tactics by adenovirus","volume":"21","author":"Baker","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0080","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1128\/JVI.77.4.2512-2521.2003","article-title":"Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber","volume":"77","author":"Nakamura","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0085","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1016\/j.biomaterials.2013.03.004","article-title":"Therapeutic efficacy of a systemically delivered oncolytic adenovirus \u2014 biodegradable polymer complex","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0090","doi-asserted-by":"crossref","first-page":"781","DOI":"10.5483\/BMBRep.2010.43.12.781","article-title":"Current advances in adenovirus nanocomplexes: more specificity and less immunogenicity","volume":"43","author":"Yun","year":"2010","journal-title":"BMB Rep."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0095","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.addr.2011.12.011","article-title":"Evolution of oncolytic adenovirus for cancer treatment","volume":"64","author":"Choi","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0100","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.1016\/j.biomaterials.2011.08.066","article-title":"Bioreducible polymer-conjugated oncolytic adenovirus for hepatoma-specific therapy via systemic administration","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/17425247.2014.874414","article-title":"Utilizing adenovirus vectors for gene delivery in cancer","volume":"11","author":"Kasala","year":"2014","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0110","first-page":"249","article-title":"The uses and properties of PEG-linked proteins","volume":"9","author":"Delgado","year":"1992","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymthe.2004.09.015","article-title":"Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses","volume":"11","author":"Mok","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0120","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1099\/0022-1317-81-11-2605","article-title":"Blood clearance rates of adenovirus type 5 in mice","volume":"81","author":"Alemany","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0125","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1089\/hum.2009.028","article-title":"Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus","volume":"20","author":"Doronin","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0130","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/10430349950018021","article-title":"PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo","volume":"10","author":"O'Riordan","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1525-0016(03)00139-4","article-title":"Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates","volume":"8","author":"Lanciotti","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0140","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1248\/bpb.27.936","article-title":"Neutralizing antibody evasion ability of adenovirus vector induced by the bioconjugation of methoxypolyethylene glycol succinimidyl propionate (MPEG-SPA)","volume":"27","author":"Eto","year":"2004","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/10430340460745766","article-title":"A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo","volume":"15","author":"Ogawara","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0150","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/jgm.699","article-title":"PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability","volume":"7","author":"Eto","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2012.12.016","article-title":"Targeted adenovirus mediated inhibition of NF-kappaB-dependent inflammatory gene expression in endothelial cells in vitro and in vivo","volume":"166","author":"Kuldo","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.npep.2011.01.002","article-title":"Pancreatic cancer bears overexpression of neurotensin and neurotensin receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell line PANC-1","volume":"45","author":"Wang","year":"2011","journal-title":"Neuropeptides"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0165","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/gut.42.4.546","article-title":"Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma","volume":"42","author":"Reubi","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0170","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.biochi.2011.04.024","article-title":"The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers","volume":"93","author":"Dupouy","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0175","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/ijc.23710","article-title":"Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway","volume":"123","author":"Shimizu","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0180","doi-asserted-by":"crossref","first-page":"e36520","DOI":"10.1371\/journal.pone.0036520","article-title":"A novel sLRP6E1E2 inhibits canonical Wnt signaling, epithelial-to-mesenchymal transition, and induces mitochondria-dependent apoptosis in lung cancer","volume":"7","author":"Lee","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1566524014666140128105352","article-title":"Wnt signaling and cell-matrix adhesion","volume":"14","author":"Astudillo","year":"2014","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0190","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.2174\/13816128112092464","article-title":"Role of Wnt\/beta-catenin signaling in drug resistance of pancreatic cancer","volume":"18","author":"Cui","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0195","series-title":"AdmTERTD19, a Conditional Replication Competent Adenovirus Driven by the Human Telomerase Promoter,Selectively Replicates in and Elicits Cytopathic Effect in a Cancer Cell-Specific Manner","author":"Kim","year":"2003"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0200","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1158\/1078-0432.CCR-10-0664","article-title":"A hypoxia- and {alpha}-fetoprotein-dependent oncolytic adenovirus exhibits specific killing of hepatocellular carcinomas","volume":"16","author":"Kwon","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0205","series-title":"Immunological Data from Cancer Patients Treated with Ad5 3-E2F-\u039424-GMCSF Suggests Utility for Tumor Immunotherapy","year":"2014"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0014-5793(99)01435-0","article-title":"Characterisation of the binding interaction between poly(L-lysine) and DNA using the fluorescamine assay in the preparation of non-viral gene delivery vectors","volume":"461","author":"Read","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0215","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jconrel.2011.12.008","article-title":"Linearized oncolytic adenoviral plasmid DNA delivered by bioreducible polymers","volume":"158","author":"Kim","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0220","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2007.08.002","article-title":"Retargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cells","volume":"123","author":"Jung","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0225","doi-asserted-by":"crossref","first-page":"e1155","DOI":"10.1371\/journal.pone.0001155","article-title":"Common activation of canonical Wnt signaling in pancreatic adenocarcinoma","volume":"2","author":"Pasca di Magliano","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0230","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/sj.gt.3301515","article-title":"CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors","volume":"8","author":"Alemany","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0235","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.molmed.2007.12.007","article-title":"The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer","volume":"14","author":"Naugler","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0240","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2013.03.030","article-title":"Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy","volume":"169","author":"Kwon","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0245","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1756-9966-29-84","article-title":"Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar","volume":"29","author":"Fei","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0250","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","article-title":"An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism","volume":"72","author":"Dmitriev","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0255","first-page":"5738","article-title":"Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer","volume":"58","author":"Miller","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0260","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1089\/104303403322611737","article-title":"Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors","volume":"14","author":"Everett","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0265","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1089\/hum.2006.17.1262","article-title":"Differential biodistribution of adenoviral vector in vivo as monitored by bioluminescence imaging and quantitative polymerase chain reaction","volume":"17","author":"Johnson","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0270","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1182\/blood.V94.12.3968","article-title":"Adenovirus-mediated expression of human coagulation factor IX in the rhesus macaque is associated with dose-limiting toxicity","volume":"94","author":"Lozier","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2015.10.015_bb0275","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/10430349950018364","article-title":"Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo","volume":"10","author":"Muruve","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0280","first-page":"356","article-title":"Overcoming the extracellular matrix barrier to improve intratumoral spread and therapeutic potential of oncolytic virotherapy","volume":"10","author":"Yun","year":"2008","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.jconrel.2015.10.015_bb0285","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fonc.2013.00193","article-title":"Strategies to increase drug penetration in solid tumors","volume":"3","author":"Choi","year":"2013","journal-title":"Front. Oncol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915301826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915301826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T16:18:11Z","timestamp":1692116291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365915301826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":57,"alternative-id":["S0168365915301826"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.10.015","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}